Publications
By Year
Now showing items 5041-5060 of 5385 records
A six-month exercise intervention in subclinical diabetic heart disease: effects on exercise capacity, autonomic and myocardial function
Baumert, M; Sacre, JW; Coombes, JS; Marwick, TH; Haluska, BA; Jenkins, C; Jellis, CL
METABOLISM - 01 Sep 2014
OBJECTIVE: Autonomic dysfunction may contribute to the etiology and exercise intolerance of subclinical diabetic heart disease. This study sought the efficacy of exercise training for improvement of peak oxygen uptake (VO₂(peak)) and cardiac autonomic function in type 2 diabetic patients with non-ischemic subclinical left-ventricular (LV) dysfunction. MATERIALS/METHODS: Forty-nine type 2 dia...
Insulin infusion reduces hepatocyte growth factor in lean humans
de Courten, B; Considine, RV; Potts, JR; Forbes, JM; Dougherty, S; de Courten, MP
METABOLISM - 01 May 2013
OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic eugl...
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
Tikellis, C; Toffoli, B; Thomas, M; Mulatero, P; Candido, R; Fabris, B; Zauli, G; Barbone, F; Catena, C; Bernardi, S; Radillo, O; Secchiero, P
MOL CELL ENDOCRINOL - 25 Aug 2014
BACKGROUND: Inflammation is believed to link obesity to insulin resistance, as in the setting of metabolic syndrome (MetS). Osteoprotegerin (OPG) is a soluble protein that seems to exert proatherogenic and prodiabetogenic effects. This study aims at determining OPG levels in MetS and whether OPG might contribute to MetS development and progression. METHODOLOGY/PRINCIPAL FINDINGS: Circulating...
Physical activity and sedentary behavior in breast and colon cancer survivors relative to adults without cancer
Boyle, T; Vallance, JK; Winkler, EA; MacInnis, RJ; Shi, JW; Lynch, BM
MAYO CLIN PROC - 01 Mar 2017
OBJECTIVE: To assess differences in accelerometer-assessed moderate- to vigorous-intensity physical activity (MVPA), light-intensity physical activity, and sedentary time between cancer survivors and adults without cancer. PATIENTS AND METHODS: Accelerometer data collected from 241 breast cancer survivors (ACCEL-Breast study, 2013) and 171 colon cancer survivors (ACCEL-Colon study, 2012-...
The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes
Sandholm, N; Harjutsalo, V; Forsblom, C; Groop, PH; Ahola, AJ; Dahlström, E; FinnDiane Study Group
KIDNEY INT - 01 May 2017
Previous studies have shown a relationship between uric acid concentration and progression of renal disease. Here we studied causality between the serum uric acid concentration and progression of diabetic nephropathy in 3895 individuals with type 1 diabetes in the FinnDiane Study. The renal status was assessed with the urinary albumin excretion rate and estimated glomerular filtration rate (eGF...
Meniscal extrusion and bone marrow lesions are associated with incident and progressive knee osteoarthritis
Wang, Y; Dodin, P; Martel-Pelletier, J; Pelletier, JP; Abram, F; Cicuttini, FM; Teichtahl, AJ
OSTEOARTHRITIS CARTILAGE - 01 Jul 2017
OBJECTIVE: Whether meniscal extrusion and bone marrow lesions (BMLs) are independently associated with the risk of knee osteoarthritis (OA) is unknown. METHODS: Data was extracted from the Osteoarthritis Initiative (OAI) cohort. Participants were grouped according to the absence (Kellgren-Lawrence (KL) grade ≤ 1, n = 2120) or presence (KL ≥ 2, n = 2249) of radiographic OA (ROA). Baseline...
Association between serum concentration of 25-hydroxyvitamin D and the risk of hip arthroplasty for osteoarthritis: result from a prospective cohort study
Shaw, JE; Wang, Y; Wluka, AE; Magliano, DJ; Hussain, SM; Graves, S; Daly, RM; Ebeling, PR; Cicuttini, FM
OSTEOARTHRITIS CARTILAGE - 01 Dec 2015
OBJECTIVES: There is ongoing debate regarding the optimal serum concentrations of 25-hydroxy-vitamin D for musculoskeletal health, including osteoarthritis (OA). The aim of this prospective cohort study was to determine whether serum 25-hydroxy-vitamin D concentrations were associated with the risk of hip arthroplasty for OA. DESIGN: This study examined 9135 participants from the Australian ...
Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study
Wang, Y; Shaw, JE; Wluka, AE; Magliano, DJ; Hussain, SM; Wong, TY; Tapp, RJ; Graves, S; Cicuttini, FM
OSTEOARTHRITIS CARTILAGE - 01 Apr 2015
OBJECTIVES: The role of the microcirculation in the pathogenesis of osteoarthritis (OA) remains unclear. This prospective cohort study examined the association between retinal vascular calibre and incidence of knee replacement for OA. DESIGN: 1838 participants of the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study had retinal vascular calibre measured using a nonmydriatic digital ...
Dietary glycotoxins exacerbate progression of experimental fatty liver disease
Goodwin, M; Mak, KY; Jia, Z; Leung, C; Angus, PW; Forbes, JM; Herath, CB; Watt, MJ
J HEPATOL - 01 Apr 2014
BACKGROUND & AIMS: Advanced glycation end-products (AGEs) levels are high in western diets and contribute to tissue injury via activation of RAGE (receptor for AGEs) and generation of reactive oxygen species (ROS). Here, we determined if high dietary AGE intake worsens progression of non-alcoholic fatty liver disease (NAFLD). METHODS: Male Sprague Dawley rats were fed a methionine choline de...
Dietary patterns are associated with various vascular health markers and complications in type 1 diabetes
Mäkimattila, S; Forsblom, C; Groop, PH; Ahola, AJ; Freese, R; FinnDiane Study Group
J DIABETES COMPLICATIONS - 01 Aug 2016
AIMS: Diet plays an important role in the management of type 1 diabetes. However, the association between dietary intake and health has not been extensively studied in this population. We studied the cross-sectional association between dietary factors, and selected vascular health markers and complications in type 1 diabetes. METHODS: Data from 874 individuals with type 1 diabetes partic...
Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation
Wolfe, R; Cooper, DJ; Pellegrino, VA; Wong, WK; Kaye, DM; Burrell, AJ; Pilcher, DV
J CRIT CARE - 01 Oct 2015
PURPOSE: This study was designed to examine the long-term survival of patients who survived to be weaned from venoarterial extracorporeal membrane oxygenation (VA ECMO) and to determine which factors present at initiation and during ECMO predict long-term survival. We further sought to develop the preliminary long-term outcome after VA ECMO score that would predict patient outcome and to ass...
The natural history of Modic changes in a community-based cohort
Wang, Y; Wluka, AE; O'Sullivan, R; Cicuttini, FM; Jones, G; Urquhart, DM; Teichtahl, AJ; Finnin, MA
JOINT BONE SPINE - 01 Mar 2017
BACKGROUND: Vertebral endplate (Modic) lesions are gaining interest, with varied phenotypes recognised to have distinct clinical and histological correlates. Nevertheless, the natural history of these lesions is unclear. This study examined the natural history of Modic changes and their potential relationship to the intervertebral disc. METHODS: Seventy-two community-based adults not sel...
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
Ashraf, TB; Kher, U; Dansky, H; DEFINE Investigators; Cannon, CP; Barter, P; Shah, S; Mitchel, Y; Davidson, M; McCrary Sisk, C; Gotto, AM; Brinton, EA
J CLIN LIPIDOL - 01 Jan 2001
BACKGROUND: In the Determining the Efficacy and Tolerability of cholesteryl ester transfer protein (CETP) INhibition with AnacEtrapib (DEFINE) trial, anacetrapib added to statin produced robust low-density lipoprotein cholesterol (LDL-C)-lowering and high-density lipoprotein cholesterol (HDL-C)-raising vs placebo in patients with coronary heart disease (CHD). Predictors of the degree of LDL-...
Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus
Derumeaux, G; Canoui-Poitrine, F; Ernande, L; Thibault, H; Ternacle, J; Moulin, P; Czibik, G; Marwick, TH; Audureau, E; Volpi, C; Jellis, CL; Henegar, C; Sawaki, D; Bergerot, C
J AM COLL CARDIOL - 03 Oct 2017
BACKGROUND: Type 2 diabetes mellitus (T2DM) may alter cardiac structure and function, but obesity, hypertension (HTN), or aging can induce similar abnormalities. OBJECTIVES: This study sought to link cardiac phenotypes in T2DM patients with clinical profiles and outcomes using cluster analysis. METHODS: Baseline echocardiography and a composite endpoint (cardiovascular mortality and ...
Catheter-based renal denervation exacerbates blood pressure fall during hemorrhage
Schlaich, MP; Singh, RR; Head, GA; Sajeesh, V; Moritz, KM; Denton, KM; McArdle, Z; Booth, LC; May, CN
J AM COLL CARDIOL - 28 Feb 2017
BACKGROUND: Clinical trials applying catheter-based radiofrequency renal denervation (RDN) demonstrated a favorable safety profile with minimal acute or procedural adverse events. Whether ablation of renal nerves adversely affects compensatory responses to hemodynamic challenge has not been extensively investigated. OBJECTIVES: The aim of this study was to examine the effect of RDN on me...
Alcohol and atrial fibrillation: a sobering review
Kalman, JM; Voskoboinik, A; Ling, LH; Kistler, PM; Prabhu, S
J AM COLL CARDIOL - 13 Dec 2016
Alcohol is popular in Western culture, supported by a perception that modest intake is cardioprotective. However, excessive drinking has detrimental implications for cardiovascular disease. Atrial fibrillation (AF) following an alcohol binge or the "holiday heart syndrome" is well characterized. However, more modest levels of alcohol intake on a regular basis may also increase the risk of AF. T...
Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction
Wright, L; Kosmala, W; Mysiak, A; Marwick, TH; Rojek, A; Przewlocka-Kosmala, M
J AM COLL CARDIOL - 25 Oct 2016
BACKGROUND: Impaired functional capacity is a hallmark of patients with heart failure with preserved ejection fraction (HFpEF). Despite the association of HFpEF with reduced myocardial compliance attributed to fibrosis, spironolactone has not been shown to alter outcomes-perhaps reflecting the heterogeneity of underlying pathological mechanisms. OBJECTIVES: The authors sought to identify...
Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease
Morton, JB; Joseph, SA; Kalman, JM; Pedagogos, E; Toussaint, N; Lee, G; Kistler, PM; Sanders, P; Wong, MC; Vohra, JK; Sparks, PB; Halloran, K
J AM COLL CARDIOL - 31 Mar 2015
Diffuse myocardial fibrosis evaluated by post-contrast T1 mapping correlates with left ventricular stiffness
Stub, D; Slavin, GS; Taylor, AJ; Ellims, AH; Hare, JL; Kaye, DM; Iles, LM; Shaw, JA
J AM COLL CARDIOL - 25 Mar 2014
OBJECTIVES: The purpose of this study was to use cardiac magnetic resonance (CMR) imaging and invasive left ventricular (LV) pressure-volume (PV) measurements to explore the relationship between diffuse myocardial fibrosis and indexes of diastolic performance in a cohort of cardiac transplant recipients. BACKGROUND: The precise mechanism of LV diastolic dysfunction in the presence of myocard...
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID study
White, HD; West, M; Tonkin, A; Sullivan, D; Thompson, P; Colquhoun, D; Keech, AC; Hunt, D; Stewart, R; Mann, K; for the LIPID study investigators; Blankenberg, S; Nestel, P; Simes, J
J AM COLL CARDIOL - 04 Feb 2014
OBJECTIVES: This study sought to assess whether baseline and change in contemporary sensitive troponin I (TnI) levels predicts coronary heart disease (CHD) death and myocardial infarction (MI), and to determine the effects of pravastatin on TnI levels. BACKGROUND: The role of troponins in predicting long-term outcomes in patients with stable CHD is not clearly defined. METHODS: The LIPID (...
Show more...